Camille L Bedrosian

Chief Medical Officer, Amylyx Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.5M

Companies

Latest trade

Sep 10, 2026

Companies

Amylyx Pharmaceuticals, Inc.Chief Medical Officer −$0.7M

Trades

AMLX Sold 10,028 shares at $32.39 $0.3M Sep 10

AMLX Sold 6,461 shares at $14.58 $0.1M Mar 2

AMLX Sold 6,580 shares at $14.35 $0.1M Dec 1

AMLX Sold 12,039 shares at $14.58 $0.2M Sep 30

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.